Nathanael Gistand
Clinical Research Coordinator
Medicine
School of Medicine

Publications (2)

Top publication keywords:
Retrospective StudiesHIV-1Drug Resistance, ViralViremiaMiddle AgedViral LoadHumansRilpivirineHIV InfectionsDiketopiperazinesPyridonesFemaleAnti-HIV AgentsAdultMale

• Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 Hickey MD, Gistand N, Grochowski J, Mayorga-Munoz F, Imbert E, Szumowski JD, Oskarsson J, Shiels M, Dilworth S, Appa A, Havlir DV, Gandhi M, Christopoulos K
• HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.
  JAMA 2025 Spinelli MA, Heise MJ, Gistand N, Cox C, Grochowski J, Oskarsson J, Glidden DV, Gandhi M